| Authors: |
Molnar KS; ViewPoint Therapeutics, South San Francisco, California, United States., Dunyak BM; ViewPoint Therapeutics, South San Francisco, California, United States., Su B; ViewPoint Therapeutics, South San Francisco, California, United States., Izrayelit Y; ViewPoint Therapeutics, South San Francisco, California, United States., McGlasson-Naumann B; Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri, United States., Hamilton PD; Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri, United States., Qian M; Department of Developmental Biology, Washington University School of Medicine, St. Louis, Missouri, United States., Covey DF; Department of Developmental Biology, Washington University School of Medicine, St. Louis, Missouri, United States., Gestwicki JE; Department of Pharmaceutical Chemistry and the Institute for Neurodegenerative Diseases, University of California at San Francisco, San Francisco, California, United States., Makley LN; ViewPoint Therapeutics, South San Francisco, California, United States., Andley UP; Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri, United States. |